AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 301.93 billion. The enterprise value is 360.29 billion.

Market Cap	301.93B
Enterprise Value	360.29B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 14, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 78.54 and the forward PE ratio is 14.90.

PE Ratio	78.54
Forward PE	14.90
PS Ratio	5.69
PB Ratio	223.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.46, with an EV/FCF ratio of 25.31.

EV / Earnings	93.72
EV / Sales	6.98
EV / EBITDA	14.46
EV / EBIT	21.07
EV / FCF	25.31

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 47.90.

Current Ratio	0.76
Quick Ratio	0.48
Debt / Equity	47.90
Debt / EBITDA	2.53
Debt / FCF	4.55
Interest Coverage	6.68

Financial Efficiency

Return on equity (ROE) is 88.40% and return on invested capital (ROIC) is 15.45%.

Return on Equity (ROE)	88.40%
Return on Assets (ROA)	8.34%
Return on Invested Capital (ROIC)	15.45%
Return on Capital Employed (ROCE)	19.06%
Revenue Per Employee	965,017
Profits Per Employee	69,895
Employee Count	55,000
Asset Turnover	0.40
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.28%
50-Day Moving Average	178.61
200-Day Moving Average	175.54
Relative Strength Index (RSI)	54.70
Average Volume (20 Days)	62

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.50

Income Statement

In the last 12 months, AbbVie had revenue of EUR 53.08 billion and earned 3.84 billion in profits. Earnings per share was 2.16.

Revenue	53.08B
Gross Profit	37.69B
Operating Income	17.59B
Pretax Income	3.35B
Net Income	3.84B
EBITDA	25.32B
EBIT	17.59B
Earnings Per Share (EPS)	2.16

Full Income Statement

Balance Sheet

The company has 4.79 billion in cash and 64.79 billion in debt, giving a net cash position of -60.00 billion.

Cash & Cash Equivalents	4.79B
Total Debt	64.79B
Net Cash	-60.00B
Net Cash Per Share	n/a
Equity (Book Value)	1.35B
Book Value Per Share	0.74
Working Capital	-8.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.17 billion and capital expenditures -940.00 million, giving a free cash flow of 14.23 billion.

Operating Cash Flow	15.17B
Capital Expenditures	-940.00M
Free Cash Flow	14.23B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 33.15% and 7.31%.

Gross Margin	71.01%
Operating Margin	33.15%
Pretax Margin	6.31%
Profit Margin	7.31%
EBITDA Margin	47.70%
EBIT Margin	33.15%
FCF Margin	26.82%

Dividends & Yields

This stock pays an annual dividend of 4.29, which amounts to a dividend yield of 2.49%.

Dividend Per Share	4.29
Dividend Yield	2.49%
Dividend Growth (YoY)	-23.24%
Years of Dividend Growth	4
Payout Ratio	266.46%
Buyback Yield	-0.03%
Shareholder Yield	2.55%
Earnings Yield	1.27%
FCF Yield	4.71%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	n/a